Pelthos Therapeutics (PTHS) EBITDA (2023 - 2026)
Pelthos Therapeutics (PTHS) posted EBITDA of -$30.4 million for Q2 2026, down 132.36% on a QoQ basis from -$13.1 million in Q1 2026, and down 841.23% year-over-year from $4.1 million in Q2 2025.
Powered by 
Analysis
Pelthos Therapeutics (PTHS) EBITDA (2023 - 2026) Analysis & Trends
Pelthos Therapeutics has reported EBITDA for 4 years, with the latest figure at -$30.4 million in Q2 2026.
- On a quarterly basis, EBITDA fell 841.23% year-over-year to -$30.4 million in Q2 2026; TTM through Jun 2026 was -$70.9 million, a 692.84% decrease from a year earlier, with the FY2025 full-year figure at -$32.4 million, down 328.35% from the prior year.
- EBITDA was -$30.4 million for Q2 2026 at Pelthos Therapeutics, down from -$13.1 million in the prior quarter.
- The five-year high for EBITDA was -$777160.0 in Q2 2023, with the low at -$30.4 million in Q2 2026.
- Average EBITDA over 4 years is -$6.5 million, with a median of -$2.0 million recorded in 2024.
- The sharpest annual moves came in 2024 and 2026: EBITDA surged 52.98% in 2024, then slumped 841.23% in 2026.
- Over 4 years, EBITDA stood at -$3.9 million in 2023, then soared by 52.98% to -$1.8 million in 2024, then slumped by 558.06% to -$12.0 million in 2025, then slumped by 153.36% to -$30.4 million in 2026.
- The last three EBITDA figures came in at -$30.4 million (Q2 2026), -$13.1 million (Q1 2026), and -$12.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.22 Bn | 620.47 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 446.22 Bn | 439.65 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 357.04 Bn | 349.90 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 268.38 Bn | 260.69 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Pfizer | 156.32 Bn | 144.62 Bn | 10.94 Bn | 4.27 Bn |
| 6 | Sanofi | 52.23 Bn | 44.85 Bn | 10.79 Bn | 1.22 Bn |
| 7 | Revolution Medicines | 43.18 Bn | 43.18 Bn | - | -505.13 Mn |
| 8 | Incyte | 24.85 Bn | 20.31 Bn | 1.57 Bn | 697.90 Mn |
| 9 | United Therapeutics | 21.29 Bn | 18.62 Bn | 683.80 Mn | 330.80 Mn |
| 10 | Pelthos Therapeutics | 80.38 Mn | 55.82 Mn | 21.23 Mn | -30.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -30.41 Mn |
| Mar 31, 2026 | -13.09 Mn |
| Dec 31, 2025 | -12.00 Mn |
| Sep 30, 2025 | -15.36 Mn |
| Jun 30, 2025 | -3.23 Mn |
| Mar 31, 2025 | -1.83 Mn |
| Dec 31, 2024 | -1.82 Mn |
| Sep 30, 2024 | -2.05 Mn |
| Jun 30, 2024 | -1.76 Mn |
| Mar 31, 2024 | -1.93 Mn |
| Dec 31, 2023 | -3.88 Mn |
| Sep 30, 2023 | -1.29 Mn |
| Jun 30, 2023 | -777,160.00 |
| Mar 31, 2023 | -914,583.00 |